OptiBiotix Health Plc (AIM:OPTI)

London flag London · Delayed Price · Currency is GBP · Price in GBX
11.08
-0.43 (-3.70%)
Jul 30, 2025, 3:27 PM GMT+1
-3.70%
Market Cap11.88M
Revenue (ttm)870.00K
Net Income (ttm)-1.81M
Shares Out103.30M
EPS (ttm)-0.02
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume109,294
Average Volume165,180
Open11.10
Previous Close11.50
Day's Range11.00 - 12.00
52-Week Range10.00 - 31.50
Beta1.69
RSI42.62
Earnings DateSep 26, 2025

About OptiBiotix Health

OptiBiotix Health Plc, a life sciences company, engages in the discovery and development of microbiome modulation products in the United Kingdom, the United States, India, China, and internationally. The company identifies and develops microbial strains, compounds, and formulations for use in food ingredients, supplements, and active compounds that can impact human physiology and derive potential health benefits. Its products include Slimbiome, which offers a scientifically supported, non-pharmaceutical approach to reduce hunger and cravings; C... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2006
Employees 10
Stock Exchange London Stock Exchange AIM
Ticker Symbol OPTI
Full Company Profile

Financial Performance

In 2024, OptiBiotix Health's revenue was 870,000, an increase of 35.09% compared to the previous year's 644,000. Losses were -1.81 million, -11.48% less than in 2023.

Financial Statements

News

There is no news available yet.